|
|
|
Insider
Information: |
Van Naarden Jacob |
Relationship: |
EVP & Pres., Loxo@Lilly |
City: |
Stamford |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
16,147 |
|
Indirect Shares
|
4,342 |
|
|
Direct
Value |
$12,234,582 |
|
|
Indirect Value
|
$3,289,933 |
|
|
Total
Shares |
20,489 |
|
|
Total
Value |
$15,524,515 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Loxo Oncology, Inc. |
LOXO |
Chief Operating Officer |
2019-02-15 |
0 |
2017-08-14 |
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
EVP & Pres., Loxo@Lilly |
2024-02-12 |
16,147 |
2024-02-12 |
4,342 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONCO |
|
2021-09-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,342 |
|
% |
|
LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONCO |
|
2021-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,692 |
|
% |
|
LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONC |
|
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,461 |
10,153 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP, CEO LoxoONC, Pres LlyONC |
|
2022-02-16 |
4 |
D |
$243.84 |
$533,034 |
D/D |
(2,186) |
7,967 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
|
2023-02-10 |
4 |
A |
$345.12 |
$830,704 |
D/D |
2,407 |
10,374 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
|
2023-02-16 |
4 |
D |
$335.01 |
$440,203 |
D/D |
(1,314) |
11,845 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP and CEO Loxo@Lilly |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,785 |
13,159 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
|
2024-02-01 |
4 |
D |
$645.61 |
$1,087,853 |
D/D |
(1,685) |
13,778 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
|
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,618 |
15,463 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP & Pres., Loxo@Lilly |
|
2024-02-12 |
4 |
A |
$737.26 |
$1,746,569 |
D/D |
2,369 |
16,147 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-08-14 |
4 |
AS |
$73.55 |
$113,619 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-08-14 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-08-15 |
4 |
AS |
$73.42 |
$113,134 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-08-15 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-09-18 |
4 |
AS |
$88.14 |
$137,462 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-09-18 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-09-19 |
4 |
AS |
$87.86 |
$136,827 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-09-19 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-10-30 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-10-30 |
4 |
AS |
$86.87 |
$134,468 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-10-31 |
4 |
AS |
$86.37 |
$133,321 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-10-31 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-11-27 |
4 |
AS |
$74.08 |
$115,316 |
D/D |
(1,541) |
0 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-11-27 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
LOXO |
Loxo Oncology, Inc. |
Chief Business Officer |
|
2017-11-28 |
4 |
OE |
$3.65 |
$5,622 |
D/D |
1,541 |
1,541 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|